OTLKW (OTLKW) News
Track canonical SquawkNews coverage tagged to OTLKW, OTLKW. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Con
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
REGULATION | Sep 10, 2026, 01:10 PM UTC
L
Outlook Therapeutics appoints CFO Kevin Lundquist
Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it prepares for a U.S. commercial launch of LYTENAVA.
EQUITY | Aug 27, 2026, 08:06 PM UTC
L
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
Outlook Therapeutics reports FY2026 Q3 results; highlights LYTENAVA FDA approval
Outlook Therapeutics (OTLKW) reports Third Quarter Fiscal Year 2026 financial results and a business update highlighting FDA approval of LYTENAVA™.
EARNINGS | Aug 14, 2026, 11:15 AM UTC
L
Outlook Therapeutics prices $55.0 million common stock and warrants offering
Outlook Therapeutics announces the pricing of a $55.0 million public offering of common stock and warrants, selling $55.0 million total under the priced terms.
EQUITY | Aug 13, 2026, 01:45 AM UTC
L
OTLK OTLKW - Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
OTLK OTLKW - Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
EQUITY | Aug 12, 2026, 08:02 PM UTC
L
OTLK OTLKW - Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and
OTLK OTLKW - Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
EARNINGS | Aug 06, 2026, 12:45 PM UTC